Linezolid CAS 165800-03-3 used for the treatment of serious infections 

Profile

Product Name: Linezolid

Synonyms: LINEZOLID;LINEZOLIDE;ACETAMIDE, N-[[(5S)-3-[3-FLUORO-4-(4-MORPHOLINYL)PHENYL]-2-OXO-5-OXAZOLIDINYL]METHYL]-;(s)-n-[[3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl]methyl]acetamide;Acetamide, N-[[(5S)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]- (9CI);Acetamide, N-[[3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-, (S)-;PNU 100766;U 100766

CAS: 165800-03-3

MF: C16H20FN3O4

MW: 337.35

Product Categories: Antibacterial;Aromatics Compounds;Aromatices;Chiral Reagents;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals;API;Pfizer compounds;TYGACIL

Mol File: 165800-03-3.mol

Description

Linezolid is a synthetic antibiotic used for the treatment of serious infections caused by Gram-positive 

bacteria that are resistant to several other antibiotics. A member of the oxazolidinone class of drugs, linezolid is active against most Grampositive bacteria that cause disease, including streptococci, vancomycinresistant enterococci(VRE), and methicillinresistant Staphylococcus aureus (MRSA).The main indications of linezolid are infections of the skin and soft tissues and pneumonia, although offlabel use for a varietyof other infections is becoming popular.

Indications

For the treatment of Gram-positive (G +) bacteria caused infections, including concurrent bacteremia; nosocomial pneumonia; community-acquired pneumonia ( because bacteria are not the same,pneumonia is clinically divided into hospital-acquired pneumonia and community-acquired pneumonia) and concomitant bacteremia; it can be applied for the complexity of the skin and skin and soft tissue infections, including osteomyelitis in diabetic foot infections; uncomplicated skin and skin and soft tissue infections; it is also used for the treatment of vancomycin-resistant feces enterococci.